Low circulating levels of IGF-1 in healthy adults are associated with reduced β-cell function, increased intramyocellular lipid, and enhanced fat utilization during fasting

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Low circulating levels of IGF-1 in healthy adults are associated with reduced β-cell function, increased intramyocellular lipid, and enhanced fat utilization during fasting. / Thankamony, Ajay; Capalbo, Donatella; Marcovecchio, M Loredana; Sleigh, Alison; Jørgensen, Sine Wanda; Hill, Nathan R; Mooslehner, Katrin; Yeo, Giles S H; Bluck, Les; Juul, Anders; Vaag, Allan; Dunger, David B.

I: Endocrinology, Bind 99, Nr. 6, 06.2014, s. 2198-2207.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Thankamony, A, Capalbo, D, Marcovecchio, ML, Sleigh, A, Jørgensen, SW, Hill, NR, Mooslehner, K, Yeo, GSH, Bluck, L, Juul, A, Vaag, A & Dunger, DB 2014, 'Low circulating levels of IGF-1 in healthy adults are associated with reduced β-cell function, increased intramyocellular lipid, and enhanced fat utilization during fasting', Endocrinology, bind 99, nr. 6, s. 2198-2207. https://doi.org/10.1210/jc.2013-4542

APA

Thankamony, A., Capalbo, D., Marcovecchio, M. L., Sleigh, A., Jørgensen, S. W., Hill, N. R., Mooslehner, K., Yeo, G. S. H., Bluck, L., Juul, A., Vaag, A., & Dunger, D. B. (2014). Low circulating levels of IGF-1 in healthy adults are associated with reduced β-cell function, increased intramyocellular lipid, and enhanced fat utilization during fasting. Endocrinology, 99(6), 2198-2207. https://doi.org/10.1210/jc.2013-4542

Vancouver

Thankamony A, Capalbo D, Marcovecchio ML, Sleigh A, Jørgensen SW, Hill NR o.a. Low circulating levels of IGF-1 in healthy adults are associated with reduced β-cell function, increased intramyocellular lipid, and enhanced fat utilization during fasting. Endocrinology. 2014 jun.;99(6):2198-2207. https://doi.org/10.1210/jc.2013-4542

Author

Thankamony, Ajay ; Capalbo, Donatella ; Marcovecchio, M Loredana ; Sleigh, Alison ; Jørgensen, Sine Wanda ; Hill, Nathan R ; Mooslehner, Katrin ; Yeo, Giles S H ; Bluck, Les ; Juul, Anders ; Vaag, Allan ; Dunger, David B. / Low circulating levels of IGF-1 in healthy adults are associated with reduced β-cell function, increased intramyocellular lipid, and enhanced fat utilization during fasting. I: Endocrinology. 2014 ; Bind 99, Nr. 6. s. 2198-2207.

Bibtex

@article{9130f986a3db4937860c084b3efb30ac,
title = "Low circulating levels of IGF-1 in healthy adults are associated with reduced β-cell function, increased intramyocellular lipid, and enhanced fat utilization during fasting",
abstract = "CONTEXT: Low serum IGF-1 levels have been linked to increased risk for development of type 2 diabetes. However, the physiological role of IGF-1 in glucose metabolism is not well characterized.OBJECTIVE: Our objective was to explore glucose and lipid metabolism associated with variations in serum IGF-1 levels.DESIGN, SETTING AND PARTICIPANTS: IGF-1 levels were measured in healthy, nonobese male volunteers aged 18 to 50 years from a biobank (n = 275) to select 24 subjects (age 34.8 ± 8.9 years), 12 each in the lowest (low-IGF) and highest (high-IGF) quartiles of age-specific IGF-1 SD scores. Evaluations were undertaken after a 24-hour fast and included glucose and glycerol turnover rates using tracers, iv glucose tolerance test to estimate peripheral insulin sensitivity (IS) and acute insulin and C-peptide responses (indices of insulin secretion), magnetic resonance spectroscopy to measure intramyocellular lipids (IMCLs), calorimetry, and gene expression studies in a muscle biopsy.MAIN OUTCOME MEASURES: Acute insulin and C-peptide responses, IS, and glucose and glycerol rate of appearance (Ra) were evaluated.RESULTS: Fasting insulin and C-peptide levels and glucose Ra were reduced (all P < .05) in low-IGF compared with high-IGF subjects, indicating increased hepatic IS. Acute insulin and C-peptide responses were lower (both P < .05), but similar peripheral IS resulted in reduced insulin secretion adjusted for IS in low-IGF subjects (P = 0.044). Low-IGF subjects had higher overnight levels of free fatty acids (P = .028) and β-hydroxybutyrate (P = .014), increased accumulation of IMCLs in tibialis anterior muscle (P = .008), and a tendency for elevated fat oxidation rates (P = .058); however, glycerol Ra values were similar. Gene expression of the fatty acid metabolism pathway (P = .0014) was upregulated, whereas the GLUT1 gene was downregulated (P = .005) in the skeletal muscle in low-IGF subjects.CONCLUSIONS: These data suggest that serum IGF-1 levels could be an important marker of β-cell function and glucose as well as lipid metabolic responses during fasting.",
keywords = "Adolescent, Adult, Fasting, Glucose, Health, Humans, Insulin-Like Growth Factor I, Insulin-Secreting Cells, Lipid Metabolism, Lipids, Male, Middle Aged, Muscle Fibers, Skeletal, Young Adult",
author = "Ajay Thankamony and Donatella Capalbo and Marcovecchio, {M Loredana} and Alison Sleigh and J{\o}rgensen, {Sine Wanda} and Hill, {Nathan R} and Katrin Mooslehner and Yeo, {Giles S H} and Les Bluck and Anders Juul and Allan Vaag and Dunger, {David B}",
year = "2014",
month = jun,
doi = "10.1210/jc.2013-4542",
language = "English",
volume = "99",
pages = "2198--2207",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0013-7227",
publisher = "Oxford University Press",
number = "6",

}

RIS

TY - JOUR

T1 - Low circulating levels of IGF-1 in healthy adults are associated with reduced β-cell function, increased intramyocellular lipid, and enhanced fat utilization during fasting

AU - Thankamony, Ajay

AU - Capalbo, Donatella

AU - Marcovecchio, M Loredana

AU - Sleigh, Alison

AU - Jørgensen, Sine Wanda

AU - Hill, Nathan R

AU - Mooslehner, Katrin

AU - Yeo, Giles S H

AU - Bluck, Les

AU - Juul, Anders

AU - Vaag, Allan

AU - Dunger, David B

PY - 2014/6

Y1 - 2014/6

N2 - CONTEXT: Low serum IGF-1 levels have been linked to increased risk for development of type 2 diabetes. However, the physiological role of IGF-1 in glucose metabolism is not well characterized.OBJECTIVE: Our objective was to explore glucose and lipid metabolism associated with variations in serum IGF-1 levels.DESIGN, SETTING AND PARTICIPANTS: IGF-1 levels were measured in healthy, nonobese male volunteers aged 18 to 50 years from a biobank (n = 275) to select 24 subjects (age 34.8 ± 8.9 years), 12 each in the lowest (low-IGF) and highest (high-IGF) quartiles of age-specific IGF-1 SD scores. Evaluations were undertaken after a 24-hour fast and included glucose and glycerol turnover rates using tracers, iv glucose tolerance test to estimate peripheral insulin sensitivity (IS) and acute insulin and C-peptide responses (indices of insulin secretion), magnetic resonance spectroscopy to measure intramyocellular lipids (IMCLs), calorimetry, and gene expression studies in a muscle biopsy.MAIN OUTCOME MEASURES: Acute insulin and C-peptide responses, IS, and glucose and glycerol rate of appearance (Ra) were evaluated.RESULTS: Fasting insulin and C-peptide levels and glucose Ra were reduced (all P < .05) in low-IGF compared with high-IGF subjects, indicating increased hepatic IS. Acute insulin and C-peptide responses were lower (both P < .05), but similar peripheral IS resulted in reduced insulin secretion adjusted for IS in low-IGF subjects (P = 0.044). Low-IGF subjects had higher overnight levels of free fatty acids (P = .028) and β-hydroxybutyrate (P = .014), increased accumulation of IMCLs in tibialis anterior muscle (P = .008), and a tendency for elevated fat oxidation rates (P = .058); however, glycerol Ra values were similar. Gene expression of the fatty acid metabolism pathway (P = .0014) was upregulated, whereas the GLUT1 gene was downregulated (P = .005) in the skeletal muscle in low-IGF subjects.CONCLUSIONS: These data suggest that serum IGF-1 levels could be an important marker of β-cell function and glucose as well as lipid metabolic responses during fasting.

AB - CONTEXT: Low serum IGF-1 levels have been linked to increased risk for development of type 2 diabetes. However, the physiological role of IGF-1 in glucose metabolism is not well characterized.OBJECTIVE: Our objective was to explore glucose and lipid metabolism associated with variations in serum IGF-1 levels.DESIGN, SETTING AND PARTICIPANTS: IGF-1 levels were measured in healthy, nonobese male volunteers aged 18 to 50 years from a biobank (n = 275) to select 24 subjects (age 34.8 ± 8.9 years), 12 each in the lowest (low-IGF) and highest (high-IGF) quartiles of age-specific IGF-1 SD scores. Evaluations were undertaken after a 24-hour fast and included glucose and glycerol turnover rates using tracers, iv glucose tolerance test to estimate peripheral insulin sensitivity (IS) and acute insulin and C-peptide responses (indices of insulin secretion), magnetic resonance spectroscopy to measure intramyocellular lipids (IMCLs), calorimetry, and gene expression studies in a muscle biopsy.MAIN OUTCOME MEASURES: Acute insulin and C-peptide responses, IS, and glucose and glycerol rate of appearance (Ra) were evaluated.RESULTS: Fasting insulin and C-peptide levels and glucose Ra were reduced (all P < .05) in low-IGF compared with high-IGF subjects, indicating increased hepatic IS. Acute insulin and C-peptide responses were lower (both P < .05), but similar peripheral IS resulted in reduced insulin secretion adjusted for IS in low-IGF subjects (P = 0.044). Low-IGF subjects had higher overnight levels of free fatty acids (P = .028) and β-hydroxybutyrate (P = .014), increased accumulation of IMCLs in tibialis anterior muscle (P = .008), and a tendency for elevated fat oxidation rates (P = .058); however, glycerol Ra values were similar. Gene expression of the fatty acid metabolism pathway (P = .0014) was upregulated, whereas the GLUT1 gene was downregulated (P = .005) in the skeletal muscle in low-IGF subjects.CONCLUSIONS: These data suggest that serum IGF-1 levels could be an important marker of β-cell function and glucose as well as lipid metabolic responses during fasting.

KW - Adolescent

KW - Adult

KW - Fasting

KW - Glucose

KW - Health

KW - Humans

KW - Insulin-Like Growth Factor I

KW - Insulin-Secreting Cells

KW - Lipid Metabolism

KW - Lipids

KW - Male

KW - Middle Aged

KW - Muscle Fibers, Skeletal

KW - Young Adult

U2 - 10.1210/jc.2013-4542

DO - 10.1210/jc.2013-4542

M3 - Journal article

C2 - 24617714

VL - 99

SP - 2198

EP - 2207

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0013-7227

IS - 6

ER -

ID: 137499912